[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@AppieAnanas Appie Ananas
Appie Ananas posts on X about $prqr, eli lilly, targets, $lly the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +17,882%
- X Month XXXXX -XX%
Mentions: X #
- X Week X +700%
- X Month XX +27%
Followers: XX #
- X Week XX +4%
- X Month XX +44%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance XX% stocks XX%
Social topic influence $prqr #1, eli lilly 16.67%, targets 8.33%, $lly 8.33%, $250share 8.33%, $250m 8.33%, longterm 8.33%, cash flow 8.33%, ip 8.33%, avg XXXX%
Top accounts mentioned or mentioned by @selsoftdataflow
Top assets mentioned Eli Lilly and Company (LLY)
Top Social Posts #
Top posts by engagements in the last XX hours
"$PRQR Oct investor conferences may quietly preview new Axiomer CNS data (AX-0810 / Rett). Some slides likely overlap with Eli Lilly-linked targets under NDA shared only with institutions. What do you think Theres something bubbling anyway"
X Link @AppieAnanas 2025-10-14T12:42Z XX followers, XXX engagements
"5/ In short: The joint patents suggest the $PRQR$LLY collaboration is broader deeper and more valuable than the market currently prices in. At $2.50/share the market still values $PRQR at only $250M well below its strategic potential. #RNAediting #biotechinvesting"
X Link @AppieAnanas 2025-10-10T07:37Z XX followers, XXX engagements
"3/ If these are co-owned IP assets $PRQR could earn royalties on multiple Eli Lilly programs adding real long-term cash flow potential. Even a XX% royalty stream on several CNS or metabolic drugs could be worth hundreds of millions over time"
X Link @AppieAnanas 2025-10-10T07:35Z XX followers, XXX engagements
"@SelsoftDataFlow If ProQRs Rett NHP data confirm safe and efficient CNS RNA editing Eli Lilly gains a strong incentive to acquire not just partner to lock down the Axiomer platform and accelerate its own neuro pipeline. $PRQR"
X Link @AppieAnanas 2025-10-15T15:21Z XX followers, XXX engagements
"2/ The patents include: WO2025155911A1 antisense oligos for Hurler syndrome (IDUA) WO2024206175A1 antisense oligos for neurological disorders (KCC2) These go far beyond liver-focused RNA editing. CNS = huge market potential"
X Link @AppieAnanas 2025-10-10T07:35Z XX followers, XX engagements
"@SelsoftDataFlow X is a nice rest stop on the climb to the top if everything goes well"
X Link @AppieAnanas 2025-10-15T15:02Z XX followers, XX engagements
"$PRQR closed strong at $XXXX (+10.16%) followed by 1.4M shares traded after hours nearly X avg daily volume. No news no hype just quiet accumulation ahead of key near-term catalysts: - AX-0810 trial start / CTA approval - CNS program visibility - Fall investor event"
X Link @AppieAnanas 2025-10-15T20:52Z XX followers, XX engagements